BioMarin Pharmaceutical Inc. was founded in 1997, and since July 1999 the company's common stock has been traded on the Nasdaq National Market under the ticker symbol BMRN. BioMarin's policy is to fully comply with all rules put forth by the Securities and Exchange Commission and the Nasdaq National Market. For misplaced stock certificates, please contact our transfer agent directly.
Events & Presentations
BioMarin Pharmaceutical Inc. Third Quarter 2016 Financial Results Conference Call
Oct 27, 2016 at 1:30 PM PT
Form 8-K - current report
Aug 11, 2016
Form 424B5 - prospectus filed pursuant to rule 424
Aug 10, 2016